- ►annals.org AJ Sanyal, AM Freedman, VA Luketic, PP … - Annals of internal medicine, 1997 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Transjugular intrahepatic portosystemic shunts (TIPS) have ... Cited by 136 - Related articles - BL Direct - All 3 versions
JP Cello, EJ Ring, EW Olcott, J Koch, R … - Annals of internal medicine, 1997 - Am Coll Physicians Background: Hemorrhage from esophageal varices remains a substantial management
problem. Endoscopic sclerotherapy was preferred for more than a decade, but
fluoroscopically placed intrahepatic portosystemic stents have recently ... Cited by 155 - Related articles - BL Direct - All 8 versions
M Merli, F Salerno, O Riggio, R de Franchis, F … - Hepatology, 1998 - interscience.wiley.com Transjugular intrahepatic portosystemic shunt (TIPS), a new technique for the
treatment of portal hypertension, has been successful in preliminary studies to
treat acute variceal hemorrhage and to prevent variceal rebleeding. The ... Cited by 106 - Related articles - BL Direct - All 3 versions
R Jalan, EH Forrest, AJ Stanley, DN Redhead, … - Hepatology, 1997 - interscience.wiley.com The aim of this study was to compare transjugular intrahepatic portosystemic
stent-shunt (TIPSS) with variceal band ligation (VBL) in the secondary
prophylaxis of esophageal variceal hemorrhage in patients with cirrhosis. ... Cited by 129 - Related articles - BL Direct - All 4 versions
P Sauer, L Theilmann, W Stremmel, C Benz, GM … - Gastroenterology, 1997 - Elsevier RESULTS: Median observation time was in 1.6 years in the TIPS group and 1.45
years in the ES group. Cumulative rates of rebleeding were 23% in the TIPS group
and 57% in the ES group (P = 0.0001). Hepatic encephalopathy was observed ... Cited by 127 - Related articles - BL Direct - All 5 versions
M Rössle, P Deibert, K Haag, A Ochs, M … - Lancet, 1997 - ncbi.nlm.nih.gov BACKGROUND: The transjugular-intrahepatic-portosystemic shunt is a new
interventional treatment for portal hypertension. The aim of our study was to
compare the transjugular shunt with endoscopic treatment for the ... Cited by 169 - Related articles - BL Direct - All 4 versions
L Garcia-Villarreal, F Martinez-Lagares, A … - Hepatology, 1999 - interscience.wiley.com Variceal hemorrhage continues to be a major cause of morbidity and mortality in
cirrhotic patients. Transjugular intrahepatic portosystemic shunt (TIPS) is
gaining wide acceptance as a treatment for several complications of portal ... Cited by 82 - Related articles - BL Direct - All 6 versions
AJ Sanyal, AM Freedman, VA Luketic, PP … - Gastroenterology, 1997 - Elsevier RESULTS: In 100 consecutive subjects, mean portosystemic gradient decreased from
24 to 11 mm Hg (means) (P < 0.001) after TIPS. Recurrent portal hypertension
caused by stent thrombosis (n = 5), stent retraction (n = 2), and stent ... Cited by 183 - Related articles - BL Direct - All 4 versions
GV Papatheodoridis, J Goulis, G Leandro, D … - Hepatology, 1999 - interscience.wiley.com Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but
this still occurs in about 50% of patients. Recently, transjugular intrahepatic
portosystemic shunt (TIPS) has been compared with ET in several trials. ... Cited by 175 - Related articles - BL Direct - All 5 versions
